How Neil Gorsuch Could Help Courts Take Power From
How Neil Gorsuch Could Help Courts Take Power From ‘Unelected Bureaucrats’
The writings of Judge Neil Gorsuch, President Donald Trump’s nominee for the Supreme Court, make clear his skepticism about government regulation and executive power.
If confirmed as a member of the Supreme Court, Gorsuch could push to limit or overturn a 33-year-old legal doctrine, known as Chevron, which says the courts should defer to executive branch agencies’ interpretations of ambiguous laws passed by Congress.
Last year, Gorsuch explicitly questioned the wisdom of the Chevron doctrine, arguing that judges should decide the meaning of the law, not federal bureaucrats.
In a 22-page concurring opinion he issued in a case before the 10th Circuit Court of Appeals called Gutierrez-Brizuela v. Lynch, Gorsuch wrote:
Gorsuch’s stance on Chevron will please conservatives who argue the Obama administration relied on this precedent aggressively.
But conservative legal experts and thinkers, including the late Justice Antonin Scalia, had embraced the doctrine when the U.S. Supreme Court adopted it in a 1984 case, Chevron U.S.A., Inc. vs. Natural Resources Defense Council.
As a result of the Supreme Court’s ruling, an agency such as the Department of Health and Human Services or the Environmental Protection Agency is able to implement policy passed by Congress how it wants when there is doubt about what lawmakers meant to enact, as long as the agency’s reading is “reasonable.”
In the case, the Supreme Court ruled that President Ronald Reagan’s Environmental Protection Agency could interpret the Clean Air Act in a way that allowed the Chevron oil company to emit more pollutants.
Indeed, Chevron has enjoyed bipartisan support in the past from those who believe it limits the power of activist judges and gives more authority to experts in their fields working for administrative agencies.
Yet today’s debate about executive power has shifted, with both parties questioning the proper use of executive power.
“This is not a Republican or Democrat issue,” said John Malcolm, director of The Heritage Foundation’s Meese Center for Legal and Judicial Studies, in an interview with The Daily Signal. “There are people on the left who criticize conservative agencies run amok and the opposite is true. If you are not a fan of wide-ranging administrative discretion, then Gorsuch’s views are music to your ears.”
Rep. John Ratcliffe, R-Texas, feels exactly this way.
Ratcliffe is one of the authors of the legislation, which passed the House last month, that directs courts, not agencies, to interpret all questions of law, including both statutes and regulations. The House sent the legislation to the Senate for it to review.
“It’s obvious from reading Judge Gorsuch’s opinions that we have a shared belief in the importance of separation of powers, and he has an expressed objection to the explosion of the administrative bureaucracy,” Ratcliffe told The Daily Signal in an interview. “That is music to my ears.”
Ratcliffe says he feels this way despite the fact that weakening or overturning Chevron would take authority away from a Republican president.
“The president will change,” Ratcliffe said. “It would be short-sighted and foolhardy for us as conservatives to be a cheerleader of Chevron just because a Republican occupies Pennsylvania Avenue. We will rue the day if the shoe is on the other foot again and Democrats are in power. What the American people should want and all members of Congress should want is Congress reasserting its authority and a judicial branch playing the role of interpreting laws rather than faceless unelected bureaucrats doing that.”
Ratcliffe says he expects Gorsuch to take an independent view of the subject, even if that means the judiciary branch becomes an obstacle for Trump to enact his agenda. He even encourages Senate Democrats to embrace Gorsuch’s views on executive power as a way to hold the Trump administration accountable.
“If you are afraid of an overreaching President Trump acting by executive order, ending Chevron deference is exactly the tool you want to restore your Article I legislative power to be that check and balance that our Founders intended and served us all well to 1984,” Ratcliffe said.
Dan Goldberg, the legal director at Alliance for Justice, a progressive judicial advocacy group, is telling Senate Democrats not to bite.
In an interview with The Daily Signal, Goldberg said Democrats should not support Gorsuch because of his views on Chevron, even if overturning the doctrine might benefit progressives in the short term.
“This is not a question of who the president is right now,” Goldberg said. “It’s a question of who Neil Gorsuch is. What he wants to do is make it much more difficult for agencies to enforce laws that ensure food and water safety, protect worker rights, and safeguard consumers and investors. Not requiring courts to defer to agency expertise will make it harder for future federal agencies to address these matters.”
Jeffrey Pojanowski, an administrative law expert at Notre Dame Law School, said the Chevron doctrine is likely to survive for now.
The professor, in an interview with The Daily Signal, said Gorsuch’s appointment to the Supreme Court could make justices more likely to at least act to weaken Chevron. If that were to happen, the judges could perhaps modify the standard of deference to raise the bar on how persuasive the agency has to be in making the case for why its interpretation of a law or rule is appropriate.
“There is no coalition to overrule Chevron,” Pojanowski said. “I don’t see anything from their opinions that enough judges would want to outright junk it, although they may be interested in domesticating it or taming it. At the very least, Gorsuch would give more opportunity to dial it back where the justices find it to be inappropriate.”
1
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...
Continue Reading
Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...
Continue Reading
Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...
Continue Reading
The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...
Continue Reading
A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...
Continue Reading
Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...
Continue Reading
Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...
Continue Reading
Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...
Continue Reading
A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...
Continue Reading
Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....
Continue Reading
Top 5 Most Recently Viewed Articles
Alphyn Biologics Unveils Innovative Clinical Trial for Atopic Dermatitis Treatment Alphyn Biologics, Inc. is making strides in its mission to address the complexities of atopic dermatitis (AD) by launching the CLEAR-AD1 Phase 2b clinical trial program. Leading this initiative is their cutting-edge product, Zabalafin Hydrogel, which is designed to effectively target the...
Continue Reading
CoreWeave Inc Experiences Major Stock Drop CoreWeave Inc (NASDAQ: CRWV) has seen its stock plummet by nearly 10% in pre-market trading, marking a significant moment for the company. The drop comes despite the firm reporting strong second-quarter revenue that outstrips projections. However, the downside appears to be linked to disappointing earnings per share (EPS), which...
Continue Reading
Understanding DeepSeek's Revolutionary AI Tools In today's rapidly evolving technological landscape, a recent development has the potential to change the rules of the game. While debates about software consuming the world continue, it's crucial to delve into the implications of DeepSeek's innovative approach. This situation may echo the historical context of the Soviet...
Continue Reading
Strategic Communications Awarded National Sourcewell Contract Strategic Communications has recently achieved a vital milestone by securing a national Sourcewell contract tailored specifically for Public Safety Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS), and various other professional technology services. This cooperative...
Continue Reading
Porter Simplifying Health Care Coordination Porter has emerged as a pioneering force in AI-driven care coordination and comprehensive clinical services at home. With a focus on Medicare Advantage, ACA Commercial, and Medicaid plans, Porter stands out as an essential in-home vendor. By integrating care coordination, in-home visits, and advanced analytics, this innovative...
Continue Reading